X
Welcome to the
Bioven website
Our focus is on cancer. Our novel immunotherapy for the treatment of lung cancer is currently in Phase III trials.

LEARN MORE
News Updates
10 Feb 2017 Pathway Targeted Immunotherapy
15 Dec 2016 Bioven GETS FDA PHASE III LUNG CANCER STUDY APPROVAL.
Bioven GETS FDA PHASE III LUNG CANCER STUDY APPROVAL.